Glucose transporter upregulation improves ischemic tolerance in hypertrophied failing heart

Circulation

Volumn 98, Issue 19 SUPPL., 1998, Pages

  Takeuchi, Koh ^a   McGowan Jr , Francis X ^a   Glynn, Paul ^a   Moran, Adrian M ^a   Rader, Christine M ^a   Cao Danh, Hung ^a   Del Nido, Pedro J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Glucose; Heart failure; Hypertrophy; Metabolism; Spectroscopy; Vanadyl sulfate

Indexed keywords

GLUCOSE TRANSPORTER; VANADYL SULFATE;

ANAEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART FAILURE; HEART MUSCLE ISCHEMIA; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR UPREGULATION; SPECTROSCOPY;

EID: 0345487519     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol. 1970;218:153-159.
2. Chevalier B, Callens F, Charlemagne D, Delcayre C, Lompre AM, Lefievre L, Mercdier JJ, Moalic JM, Mansier P, Rappaport L, Samuel J, Schwartz R, Seynghedauw B. Signal and adaptational changes in gene expression during cardiac overload. J Mol Cell Cardiol. 1989;21:71-77.
3. del Nido PJ, Nakamura H, Jimenez E, Sarin M, Feinberg H, Levitsky S. The effect of cardiac hypertrophy upon changes in cytosolic free calcium concentration during ischemia. Surgery. 1990;108:312-317.
4. 2+-ATPase during progression of left ventricular hypertrophy. Am J Physiol. 1997;272:H2416-2424.
5. Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension. 1988;11:416-426.
6. Takeuchi K, Buenaventura P, Cao-Danh H, Glynn P, Simplaceaneau E, McGowan FX, and del Nido PJ. Improved protection of the hypertrophied left ventricle by histidine-containing cardioplegia. Circulation. 1995; 92(suppl II):II-395-II-399.
7. Paternostro G, Clarke K, Heath J, Seymour A-M L, Radda GK. Decreased GLUT-4 mRNA and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res. 1995;2:205-211.
8. Schwaiger M, Neese R, Araujo C, Wyns W, Wisneski J, Sokov H, Swank S, Kulbert D, Selin C, Phelps M, Schelben H, Fishbein M, Gertz E. Sustained non-oxidative glucose utilization and depletion of glycogen in reperfused myocardium. J Am Coll Cardiol. 1989;13:745-754.
9. Owen P, Dennis S, Opie LH. Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Cire Res. 1990;66: 344-354.
10. Ohkado A, Cao-Danh H, Sommers KE, del Nido PJ. Evaluation of highly buffered low calcium solution for the long term preservation of the heart: comparison with University of Wisconsin solution. J Thorac Cardiovasc Surg. 1994;108:762-771.
11. McGowan FX Jr, Cao-Danh H, Takeuchi K, Davis PJ, del Nido PJ. Prolonged neonatal myocardial preservation with a highly buffered low calcium solution. J Thorac Cardiovasc Surg. 1994;108:772-779.
12. Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol. 1992;54:911-930.
13. Kraegen EW, Sowden JA, Halstead MB, Clark PW, Rodnick KJ, Chisholm DJ, James DE. Glucose transporters and in vivo glucose uptake in skeletal muscle and cardiac muscle: fasting, insulin stimulation, and immunoisolation studies of GLUT1 and GLUT4. Biochem J. 1993;295: 287-293.
14. Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci U S A. 1991;88:7815-7819.
15. Ramanadham S, Mongold JJ, Brownsey RW, Cros GH, McNeill JH. Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol. 1989;257:H904-H911.
16. 2+, and insulin on 2-deoxyglucose uptake and phosphorylation in perfused rat heart. Biochim Biophys Acta. 1986;889:225-235.
17. Young LH, Renfu Y, Rusell R, Xiaoyue H, Caplan M, Ren J, Shulman GI, Sinusas AJ. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 1997;95:415-422.
18. Manchester J, Kong X, Nerbonne J, Lowry OH, Lawrence JC. Glucose transport and phosphorylation in single cardiac myocytes: rate-limiting steps in glucose metabolism. Am J Physiol. 1994;266:E326-E333.
19. Kagaya T, Kanno Y, Takeyama D, Ishida N, Maruyama Y, Takahashi T, Ido T, Takishima T. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. Circulation. 1990; 81:1353-1361.
20. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidative enzyme gene expression is downregulated in the failing heart. Circulation. 1996;94:2837-2842.
21. Busch PM. Vanadium: A Materials Survey. Washington, DC: Bureau of Mines; 1961. US Dept of Interior IC 8060.
22. Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetic mellitus. J Clin Invest. 1995;95:2501-2509.
23. 45Ca-efflux and sugar transport in adipose tissue and in skeletal muscle. Biochim Biophys Acta. 1981;646:261-267.
24. Clark AS, Fagan JM, and Mitch WE. Selectivity of the insulin-like actions of vanadate on glucose and protein metabolism in skeletal muscle. Biochem J. 1985;232:273-276.
25. Curran GL. Effect of certain transition group elements on hepatic synthesis of cholesterol in the rat. J Biol Chem. 1954;210:765-770.
26. Shechter Y, Karlish SJ. Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature. 1980;284:556-558.
27. Chernoff J, Li HC. A major phosphotyrosyl-protein phosphatase from bovine heart is associated with low molecular weight acid phosphatase. Arch Biochem Biophys. 1985;240:135-145.
28. Tracey AS, Gresser MJ. Interaction of vanadate with phenol and tyrosine. Implications for the effects of vanadate on systems regulated by tyrosine phosphorylation. Proc Natl Acad Sci U S A. 1986;83:609-613.
29. Mongold JJ, Cross GH, Vian L, Tep A, Ramanadham S, Siou G, Diaz J, McNeill JH, Serrano JJ. Toxicological aspects of vanadyl sulfate on diabetic rats: effects on vanadium levels and pancreatic β-cell morphology. Pharmacol Toxicol. 1990;67:192-198.
30. Domingo JL, Gomez M, Llobet M, Corbella J, Keen CL. Oral vanadium administration to streptozocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used. Toxicology. 1991;66:279-287.
31. Owuso-Yau J, Cohen SY, Wei CI. An assessment of the genotoxicity of vanadium. Toxicol Lett. 1990;50:327-336.
32. Sabbioni E, Pozzi G, Pintar A, Casella L, and Garattini S. Cellular retention, cytotoxicity and morphological transformation by vanadium(IV) and vanadium(V) in BALB/3T3 cell lines. Carcinogenesis. 1991;12:47-52.